Abstract
BackgroundIn developing countries, child health outcomes are influenced by the non-availability of priority life-saving medicines at public sector health facilities and non-affordability of medicines at private medicine outlets. This study aimed to assess availability, price components and affordability of priority life-saving medicines for under-five children in Tigray region, Northern Ethiopia.MethodsA cross-sectional study was conducted in Tigray region from December 2015 to July 2016 using a standard method developed by the World Health Organization and Health Action International (WHO/HAI). Data on the availability and price of 27 priority life-saving medicines were collected from 31 public and 10 private sectors. Availability and prices were expressed in percent and median price ratios (MPRs), respectively. Affordability was reported in terms of the daily wage of the lowest-paid unskilled government worker.ResultsThe overall availability of priority life-saving drugs in this study was low (34.1%). The average availabilities of all surveyed medicines in public and private sectors were 41.9 and 31.5%, respectively. The overall availability of medicines for malaria was found to be poor with average values of 29.3% for artemisinin combination therapy tablet, 19.5% for artesunate injection and 0% for rectal artesunate. Whereas, the availability of oral rehydration salt (ORS) and zinc sulphate dispersible tablets for the treatment of diarrhea was moderately high (90% for ORS and 82% for zinc sulphate). Medicines for pneumonia showed an overall percent availability in the range of 0% (ampicillin 250 mg and 1 g powder for injection and oxygen medicinal gas) to 100% (amoxicillin 500 mg capsule). The MPRs of 12 lowest price generic medicines were 1.5 and 2.7 times higher than the international reference prices (IRPs) for the private and public sectors, respectively. About 30% of priority life-saving medicines in the public sector and 50% of them in the private sector demanded above a single daily wages to purchase the standard treatment of the prevalent diseases of children.ConclusionsThe lower availability, high price and low affordability of lowest price generic priority life-saving medicines in public and private sectors reflect a failure to implement the health policy on priority life-saving medicines in the region.
Highlights
Being a critical improvement indicator of health, socioeconomic status and quality of life of a given population, there has been a global drive to improve the under-five children mortality rate during the past three decades [1]
The availability of medicines was found to vary with the type of medicine and sector
The availability of all life-saving medications in public outlets was higher than private sector except for paracetamol 200 mg suppository and oral rehydration salt (ORS)
Summary
Being a critical improvement indicator of health, socioeconomic status and quality of life of a given population, there has been a global drive to improve the under-five children mortality rate during the past three decades [1]. In Ethiopia, children under-five mortality rate was reported to be 67 per 1000 live births in 2015, with one in every fifteen children dying before their fifth birthday [4]. According to the United Nations (UN) commission on life-saving commodities for women and children, many of these deaths are due to conditions such as pneumonia, diarrhea and malaria, which could be prevented or treated by simple and affordable medicines administered before, during and immediately after birth [5]. Early diagnosis and treatment with simple antibiotics could avert as many as 600,000 of deaths in case of pneumonia whereas, improving access to ORS would save as many of 1.3 million children who are dying annually from diarrhea [3, 7]. This study aimed to assess availability, price components and affordability of priority life-saving medicines for underfive children in Tigray region, Northern Ethiopia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.